Kyowa boosts GABA manufacturing
(gamma-amino butyric acid), with the launch of a new supplement,
Remake GABA, which helps to lower blood pressure and promote
Japan's Kyowa Hakko is to step up production of the amino acid GABA (gamma-amino butyric acid), with the launch of a new supplement, Remake GABA, which helps to lower blood pressure and promote relaxation.
The company, known in Japan for its soy-based cholesterol-lowering formula CSPHP, will also start volume production of concentrated GABA for the dietary and supplement industry, said a report from Japan Corporate News Network.
Two tablets of Remake GABA contain 65mg of GABA or the same amount found in two bowls of brown rice, according to the firm. The product will be marketed through its catalogue retailer, Kyowa High Foods K.K.
Kyowa Hakko has used its fermentation technology to develop a highly concentrated GABA that is easily soluble in water and is stable.
GABA, an inhibitory neurotransmitter, is sometimes taken to enhance sleep quality. It is also used increasingly in bodybuilding supplements for its effect on growth hormone levels.
Last week a European court upheld the European Commission's €13.2 million fine on Kyowa for participation in a lysine cartel.